ASML vs MAR: Which Is the Better Buy?

Side-by-side comparison of ASML Holding N.V. and Marriott International, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-20.
ASML Holding N.V. Β· Technology
$1,775.64
+45.0% upside to fair value
Grade B High Quality
VS
Marriott International, Inc. Β· Consumer Cyclical
$366.24
-3.4% upside to fair value
Med Conviction Grade C
QuantHub Verdict
ASML has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ASML MAR
Current Price $1,775.64 $366.24
Fair Value Estimate $2,574.68 $353.64
Upside to Fair Value +45.0% -3.4%
Market Cap $684.4B $96.6B
Forward P/E 62.1x β€”
EV / EBITDA 47.1x 23.8x
Price / Sales 18.4x 3.7x
Price / FCF 69.1x 31.6x
Revenue Growth YoY +13.2% +6.2%
Gross Margin 52.6% 21.4%
Operating Margin 34.8% 16.0%
Return on Equity 52.0% -74.1%
Dividend Yield 0% 0.75%
FCF Yield 1.45% 3.17%
Analyst Consensus Strong Buy Hold
Investment Thesis
ASML β€” ASML Holding N.V.
ASML Holding N.V. is a leading semiconductor equipment manufacturer specializing in photolithography systems critical for chip production. The company exhibits high business quality with a durable competitive moat supported by advanced technology and strong market position, reflected in a 52% return on equity and robust margins including a 52.6% gross margin and 29.7% net margin. Despite strong r…
MAR β€” Marriott International, Inc.
Marriott International is a global asset-light hotel franchisor, manager and licensor whose high-quality brands, nearly 283 million Bonvoy members, more than 9,900 properties across 146 countries and record 4,107-property development pipeline create meaningful network, distribution and brand advantages. Q1 2026 demonstrated resilient underlying fee economics: adjusted revenue excluding cost-reimb…
Accumulation Zones
Metric ASML MAR
Zone Low $1,931.01 $265.23
Zone High $2,188.48 $300.59
In Buy Zone? Yes No
← ASML Research    MAR Research β†’    All Research